تفاعل #1726710

ord-cfe4896ea39641d6b135935f967bdf42

معادلة التفاعل

O=C1CCNCC1
4-piperidone
COc1ccc(O)c(C(N)=O)c1
2-hydroxy-5-methoxybenzamide
C1COCCN1
morpholine
COc1ccc2c(c1)C(=O)NC1(CCNCC1)O2
Compound 150
COc1ccc2c(c1)C(=O)NC1(CCNCC1)O2
6-methoxyspiro-[2H-1,3-benzoxazin-2,4′-piperidin]-4-(3H)-one

الكواشف

لا شيء

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    درجة الحرارةis refluxed for 20 hr
  2. 2
    غسيلwashed with water, brine
  3. 3
    تجفيفdried over Na2SO4
  4. 4
    أخرىAfter solvent removal by rotoevaporation
  5. 5
    أخرىthe crude product is purified by preparative TLC

الإجراء التجريبي

A mixture of 26 mg (0.083 mmol) of N-[4,8-dimethoxyquinoline-2-yl)carbonyl]-4-piperidone (prepared as described in Example 44), 14 mg (0.083 mmol) of 2-hydroxy-5-methoxybenzamide, and 0.020 mL of morpholine in a mixture of 0.2 mL of toluene and 0.6 mL of methanol is refluxed for 20 hr. The reaction mixture is diluted with ethyl acetate, and washed with water, brine, and dried over Na2SO4. After solvent removal by rotoevaporation, the crude product is purified by preparative TLC to give 17 mg (0.037 mmol, 45% yield) of 1′-[4,8-dimethoxyquinoline-2-yl)carbonyl]-6-methoxyspiro-[2H-1,3-benzoxazin-2,4′-piperidin]-4-(3H)-one (Compound 150): 1H NMR (DMSO-d6): δ 3.76 (s, 3H), 3.95 (s, 3H), 4.07 (s, 3H), 7.04 (d, 1H), 7.12 (d of d, 1H), 7.19 (s, 1H), 7.24 (m, 2H), 7.52 (d of d, 1H), 7.68 (d, 1H), and 8.85 ppm (s, 1H). MS m/z: 464.1 (M+H)+, 486.2 (M+Na)+.

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08110570B2uspto-grants-2012_02